Stanislav Glezer is EVP & R&D & Chief Med. Officer at Inogen Inc (INGN). They have made 1 open-market trade across 1 company since 2022, most recently 2024-05-01.
CIK 0001866861
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| INGN | 48,744 | $305K |
Shares reported on the most recent Form 4, priced at the 2024-05-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| INGN | SELL | 2022-09-01 | 2022-09-06 | $28.16 | $44K | -2.6% | -16.4% | -22.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.